dc.contributor.author
Bousquet, Jean
dc.contributor.author
Czarlewski, Wienczyslawa
dc.contributor.author
Zuberbier, Torsten
dc.contributor.author
Mullol, Joaquim
dc.contributor.author
Blain, Hubert
dc.contributor.author
Cristol, Jean-Paul
dc.contributor.author
De La Torre, Rafael
dc.contributor.author
Pizarro Lozano, Nieves
dc.contributor.author
Le Moing, Vincent
dc.contributor.author
Bedbrook, Anna
dc.contributor.author
Agache, Ioana
dc.contributor.author
Akdis, Cezmi A.
dc.contributor.author
Canonica, G. Walter
dc.contributor.author
Cruz, Alvaro A.
dc.contributor.author
Fiocchi, Alessandro
dc.contributor.author
Fonseca, Joao A.
dc.contributor.author
Fonseca, Susana
dc.contributor.author
Gemicioğlu, Bilun
dc.contributor.author
Haahtela, Tari
dc.contributor.author
Iaccarino, Guido
dc.contributor.author
Ivancevich, Juan Carlos
dc.contributor.author
Jutel, Marek
dc.contributor.author
Klimek, Ludger
dc.contributor.author
Kraxner, Helga
dc.contributor.author
Kuna, Piotr
dc.contributor.author
Larenas-Linnemann, Désirée E.
dc.contributor.author
Martineau, Adrian
dc.contributor.author
Melén, Erik
dc.contributor.author
Okamoto, Yoshitaka
dc.contributor.author
Papadopoulos, Nikolaos G.
dc.contributor.author
Pfaar, Oliver
dc.contributor.author
Regateiro, Frederico S.
dc.contributor.author
Reynes, Jacques
dc.contributor.author
Rolland, Yves
dc.contributor.author
Rouadi, Philip W.
dc.contributor.author
Samolinski, Boleslaw
dc.contributor.author
Sheikh, Aziz
dc.contributor.author
Toppila-Salmi, Sanna
dc.contributor.author
Valiulis, Arunas
dc.contributor.author
Choi, Hak-Jong
dc.contributor.author
Kim, Hyun Ju
dc.contributor.author
Anto, Josep M.
dc.date.accessioned
2022-08-15T11:19:45Z
dc.date.available
2022-08-15T11:19:45Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/35887
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-35602
dc.description.abstract
In this article, we propose that differences in COVID-19 morbidity may be associated with transient receptor potential ankyrin 1 (TRPA1) and/or transient receptor potential vanilloid 1 (TRPV1) activation as well as desensitization. TRPA1 and TRPV1 induce inflammation and play a key role in the physiology of almost all organs. They may augment sensory or vagal nerve discharges to evoke pain and several symptoms of COVID-19, including cough, nasal obstruction, vomiting, diarrhea, and, at least partly, sudden and severe loss of smell and taste. TRPA1 can be activated by reactive oxygen species and may therefore be up-regulated in COVID-19. TRPA1 and TRPV1 channels can be activated by pungent compounds including many nuclear factor (erythroid-derived 2) (Nrf2)-interacting foods leading to channel desensitization. Interactions between Nrf2-associated nutrients and TRPA1/TRPV1 may be partly responsible for the severity of some of the COVID-19 symptoms. The regulation by Nrf2 of TRPA1/TRPV1 is still unclear, but suggested from very limited clinical evidence. In COVID-19, it is proposed that rapid desensitization of TRAP1/TRPV1 by some ingredients in foods could reduce symptom severity and provide new therapeutic strategies.
en
dc.subject
Pungent foods
en
dc.subject
Cough challenge
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1159/000514204
dcterms.bibliographicCitation.journaltitle
International Archives of Allergy and Immunology
dcterms.bibliographicCitation.number
4
dcterms.bibliographicCitation.originalpublishername
Karger
dcterms.bibliographicCitation.pagestart
324
dcterms.bibliographicCitation.pageend
338
dcterms.bibliographicCitation.volume
182
dcterms.rightsHolder.note
Copyright applies in this work.
dcterms.rightsHolder.url
http://rightsstatements.org/vocab/InC/1.0/
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.note.author
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
de
refubium.note.author
This publication is shared with permission of the rights owner and made freely accessible through a DFG (German Research Foundation) funded license at either an alliance or national level.
en
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
33567446
dcterms.isPartOf.issn
1018-2438
dcterms.isPartOf.eissn
1423-0097